» Articles » PMID: 39950118

Hydrogen-oxygen Mixture Inhalation As an Adjunctive Treatment to Home-based Exercise in Older Patients with Knee Osteoarthritis: an Open-label, Blinded-endpoint, Randomized Controlled Trial

Overview
Journal Front Pharmacol
Date 2025 Feb 14
PMID 39950118
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Knee osteoarthritis (KOA) is a degenerative joint condition, leading to disability and diminished quality of life. Molecular hydrogen has been proven to have antioxidant and anti-inflammatory properties, but few studies have investigated its effects on osteoarthritis. Our study aims to assess the therapeutic potential of hydrogen-oxygen mixture (H-O) inhalation for KOA.

Methods: In this randomized controlled trial, eligible elderly KOA patients were randomly assigned to either Group H or Group C. Both groups participated in a 12-week home-based exercise (HBE) program, which included knee-joint exercises and health education. Group H additionally received H-O inhalation for 60 min per day over 2 weeks, while Group C did not. The primary outcome was measured using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Secondary outcomes included inflammation levels (hs-CRP, NLR, PLR, LMR), Chair Stand Test (CST), Timed Up and Go (TUG), 36-item short-form health survey (SF-36), Exercise Adherence Rating Scale (EARS), and adverse events.

Results: A total of 121 subjects were enrolled, with an average age of 81.2 years, and 80.2% were female. The between-group mean difference in the WOMAC total score was -5.2 (95% CI -12.1 to 1.7, P = 0.140) at week 12, with Group H showing an improvement of -22.9 (95% CI -26.3 to -19.6, P < 0.001) and Group C showing an improvement of -19.4 (95% CI -22.7 to -16.0, P < 0.001) compared to baseline, revealing a significant group × time interaction (F (3, 356.034) = 14.425, P < 0.001). No significant differences were observed between both groups at week 12 in CST, TUG, SF-36 scores, EARS scores, or the incidence of adverse events.

Conclusion: Although clinical significance was not achieved, H-O inhalation alleviated KOA symptoms and enhanced functional activity in elderly patients undergoing the HBE program during the initial 2 weeks. However, its sustained effects on improving KOA symptoms were not observed.

References
1.
Sun X, Zhen X, Hu X, Li Y, Gu S, Gu Y . Osteoarthritis in the Middle-Aged and Elderly in China: Prevalence and Influencing Factors. Int J Environ Res Public Health. 2019; 16(23). PMC: 6926632. DOI: 10.3390/ijerph16234701. View

2.
Chen J, Kong X, Lv Y, Qin S, Sun X, Mu F . "Real world survey" of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients. Med Gas Res. 2019; 9(3):115-121. PMC: 6779007. DOI: 10.4103/2045-9912.266985. View

3.
Lin Y, Ohkawara B, Ito M, Misawa N, Miyamoto K, Takegami Y . Molecular hydrogen suppresses activated Wnt/β-catenin signaling. Sci Rep. 2016; 6:31986. PMC: 5001535. DOI: 10.1038/srep31986. View

4.
Liu Q, Niu J, Huang J, Ke Y, Tang X, Wu X . Knee osteoarthritis and all-cause mortality: the Wuchuan Osteoarthritis Study. Osteoarthritis Cartilage. 2015; 23(7):1154-7. DOI: 10.1016/j.joca.2015.03.021. View

5.
Ishibashi T, Sato B, Rikitake M, Seo T, Kurokawa R, Hara Y . Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Med Gas Res. 2012; 2(1):27. PMC: 3563451. DOI: 10.1186/2045-9912-2-27. View